Please Wait.....
Report
Saudi Arabia In-vitro Diagnostics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026 - 2031)
Market Report I 2026-02-09 I 60 Pages I Mordor Intelligence
Saudi Arabia In-vitro Diagnostics Market Analysis
The Saudi Arabia in vitro diagnostics market is expected to grow from USD 1.05 billion in 2025 to USD 1.09 billion in 2026 and is forecast to reach USD 1.31 billion by 2031 at 3.81% CAGR over 2026-2031. Momentum stems from Vision 2030 reforms that elevate diagnostics from hospital cost centers to revenue-generating services, while the Saudi Genome Program accelerates adoption of molecular platforms. Supply of reagents remains buoyant because routine diabetes and cardio-metabolic screening consume large kit volumes. Point-of-care uptake quickens as 5G-enabled IoMT links rural devices to urban specialists, and stricter SFDA rules reward firms with robust compliance capabilities. Competitive intensity is moderate; multinationals hold strong footprints, yet Lifera and other domestic entrants gain ground under Saudization quotas.
Saudi Arabia In-vitro Diagnostics Market Trends and Insights
Rising Prevalence of Diabetes & Cardio-Metabolic Disorders
Saudi Arabia allocates USD 26 billion yearly to diabetes management, translating into high volumes of glucose, HbA1c, and lipid tests across hospitals, pharmacies, and home settings. Continuous glucose monitoring attracts affluent populations seeking proactive care. Worksite wellness programs broaden point-of-care demand, and AI-driven analytics enrich diagnostic value by predicting glycemic excursions. Collectively these factors sustain consumable use and stabilize equipment refresh cycles across the Saudi Arabia in vitro diagnostics market.
Expansion of Private Healthcare Facilities
Vision 2030 aims to transition 290 hospitals and 2,300 primary centers into private management, reshaping revenue models toward fee-for-service diagnostics. Health clusters managed by the new Holding Company treat laboratories as profit centers, prompting procurement of high-throughput analyzers. At NEOM, an entirely digital hospital ecosystem illustrates end-to-end diagnostic integration and AI triage. International vendors partner with Saudi investors to localize assembly lines and satisfy Saudization quotas, reinforcing domestic capacity without diluting global quality standards.
Limited Reimbursement for Advanced Assays
Private insurers reimburse basic panels at higher ratios than next-generation sequencing, discouraging rapid uptake of costly molecular tests. Hospitals navigating fee-for-service models hesitate to absorb uncovered expenses, slowing oncology companion-diagnostic diffusion. Negotiated volume discounts partially offset costs but squeeze smaller laboratories. Until coverage broadens, high-complexity testing remains concentrated in academic centers, tempering broader Saudi Arabia in vitro diagnostics market penetration.
Other drivers and restraints analyzed in the detailed report include:
Adoption Surge in Point-of-Care & Home TestingMandatory Premarital & Pre-Employment Screening ProgramsStringent SFDA Approval Timelines
For complete list of drivers and restraints, kindly check the Table Of Contents.
Segment Analysis
Clinical chemistry retained 35.10% of the Saudi Arabia in vitro diagnostics market share in 2025, reflecting sustained diabetes and lipid testing volumes. Molecular diagnostics, propelled by the Saudi Genome Program's 100,000 whole-genome sequences, is forecast to log a 7.95% CAGR to 2031, elevating the Saudi Arabia in vitro diagnostics market size for advanced assays. Immunoassays benefit from expanded autoimmune and infectious disease profiling, while hematology tests anchor routine inpatient panels.
Investment in next-generation sequencers at King Faisal Specialist Hospital underpins personalized oncology care and pharmacogenomics. AI-enabled workflows shorten analysis times, and localized variant databases improve diagnostic accuracy for Saudi populations. As genomic literacy rises among clinicians, adoption of companion diagnostics for targeted therapies accelerates, reshaping laboratory menus across tertiary centers.
Reagents and kits comprised 68.00% of 2025 revenue, underpinned by recurring purchases for chronic disease monitoring. Instruments are projected to deliver a 9.40% CAGR through 2031, expanding the Saudi Arabia in vitro diagnostics market size for capital equipment across new hospital builds. Automation systems that integrate pre- and post-analytics attract labs grappling with workforce shortages.
Flagship projects, such as the 23-story oncology and liver center at KFSHRC, require consolidated analyzers capable of processing diverse test panels. Domestic distributors broaden service footprints to guarantee uptime, and cold-chain expansions safeguard reagent integrity, further enhancing instrument utilization rates.
The Saudi Arabia In-Vitro Diagnostics Market Report is Segmented by Test Type (Clinical Chemistry, Molecular Diagnostics, Immuno-Diagnostics, and More), Product (Instruments, Reagents and Kits), Usability (Disposable IVD Devices and Re-Usable IVD Devices), Application (Infectious Disease, Diabetes, and More), and End-User (Diagnostic Laboratories, Hospitals and More). The Market Forecasts are Provided in Terms of Value (USD).
List of Companies Covered in this Report:
Abbott Laboratories Al Borg Diagnostics Al Razi Medical Labs Becton Dickinson (BD) bioMerieux Bio-Rad Laboratories Dammam Regional Laboratory Danaher (Cepheid & Beckman Coulter) DiaSorin Fujifilm Wako Intelligent Bio Solutions / QabasTech King Faisal Specialist Hospital Labs Lifera (Saudi PIF biotech arm) QIAGEN Roche Saudi Diagnostic Laboratory Co. Siemens Healthineers Sysmex Saudi LLC Thermo Fisher Scientific Werfen
Additional Benefits:
The market estimate (ME) sheet in Excel format
3 months of analyst support
1 Introduction
1.1 Study Assumptions & Market Definition
1.2 Scope of the Study
2 Research Methodology
3 Executive Summary
4 Market Landscape
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Prevalence of Diabetes & Cardio-Metabolic Disorders
4.2.2 Expansion of Private Healthcare Facilities (Vision 2030 PPPs)
4.2.3 Adoption Surge in Point-of-Care & Home Testing
4.2.4 Mandatory Premarital & Pre-Employment Screening Programs
4.2.5 Saudi Genome Program Fuels Demand for Molecular Diagnostics
4.2.6 5G-Enabled IoMT Connecting Rural Diagnostics
4.3 Market Restraints
4.3.1 Limited Reimbursement for Advanced Assays
4.3.2 Stringent SFDA Approval Timelines
4.3.3 Skilled-Lab Workforce Shortages Under Saudization
4.3.4 Geopolitical & Cold-Chain Supply Vulnerabilities
4.4 Supply-Chain Analysis
4.5 Regulatory Landscape
4.6 Technological Outlook
4.7 Porter's Five Forces
4.7.1 Threat of New Entrants
4.7.2 Bargaining Power of Buyers
4.7.3 Bargaining Power of Suppliers
4.7.4 Threat of Substitutes
4.7.5 Competitive Rivalry
5 Market Size & Growth Forecasts (Value, USD)
5.1 By Test Type
5.1.1 Clinical Chemistry
5.1.2 Molecular Diagnostics
5.1.3 Immuno-Diagnostics
5.1.4 Hematology
5.1.5 Other Types
5.2 By Product
5.2.1 Instruments
5.2.2 Reagents & Kits
5.3 By Usability
5.3.1 Disposable IVD Devices
5.3.2 Re-usable IVD Devices
5.4 By Application
5.4.1 Infectious Disease
5.4.2 Diabetes
5.4.3 Oncology
5.4.4 Cardiology
5.4.5 Other Applications
5.5 By End-User
5.5.1 Diagnostic Laboratories
5.5.2 Hospitals & Clinics
5.5.3 Home-Care & POC Settings
5.5.4 Other End-Users
6 Competitive Landscape
6.1 Market Concentration
6.2 Market Share Analysis
6.3 Company Profiles (includes Global-level Overview, Market-level Overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share, Products & Services, Recent Developments)
6.3.1 Abbott Laboratories
6.3.2 Al Borg Diagnostics
6.3.3 Al Razi Medical Labs
6.3.4 Becton Dickinson (BD)
6.3.5 bioMerieux
6.3.6 Bio-Rad Laboratories
6.3.7 Dammam Regional Laboratory
6.3.8 Danaher (Cepheid & Beckman Coulter)
6.3.9 DiaSorin
6.3.10 Fujifilm Wako
6.3.11 Intelligent Bio Solutions / QabasTech
6.3.12 King Faisal Specialist Hospital Labs
6.3.13 Lifera (Saudi PIF biotech arm)
6.3.14 Qiagen N.V.
6.3.15 Roche Diagnostics
6.3.16 Saudi Diagnostic Laboratory Co.
6.3.17 Siemens Healthineers
6.3.18 Sysmex Saudi LLC
6.3.19 Thermo Fisher Scientific
6.3.20 Werfen
7 Market Opportunities & Future Outlook
7.1 White-Space & Unmet-Need Assessment
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security